SCHEMBL6366605

SCHEMBL6366605

COc1ccc(CSc2cccc3c2C(=O)c2cccc(SCc4ccc(OC)cc4)c2C3=O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.46
MAOA P21397 1/20 0.46
APP P05067 1/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
BCHE P06276 1/20 0.43
ACHE P22303 1/20 0.43
NSD2 O96028 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
DAO P14920 1/20 0.43
CASP3 P42574 1/20 0.43
CTSB P07858 1/20 0.42
LMNA P02545 1/20 0.42
MMP13 P45452 1/20 0.42
CHRM5 P08912 1/20 0.42
TUBB4A P04350 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9641920 0.81 MAPT (0.47) MAOBMAOAMEN1KMT2ANSD2
SCHEMBL6366697 0.81 POLB (0.52) MAOBMAOAMEN1KMT2ANSD2
SCHEMBL11409399 0.81 KDM4E (0.41) MEN1KMT2ANSD2LMNAMAPT
SCHEMBL31318416 0.76 MAOB (0.48) MAOBMAOAAPPMEN1KMT2A
SCHEMBL11409402 0.75 KDM4E (0.43) MEN1KMT2ANSD2LMNAMAPT
SCHEMBL9713483 0.74 IDO1 (0.50) MEN1KMT2ANSD2L3MBTL1LMNA
SCHEMBL10687383 0.73 APP (0.58) MAOBMAOAAPPMEN1KMT2A
SCHEMBL7298052 0.73 POLB (0.65) MAOBMAOAAPPMEN1KMT2A
SCHEMBL12603762 0.73 RAB9A (0.51) MAOBMAOAAPPMEN1KMT2A
SCHEMBL6365511 0.72 S100A4 (0.47) MAOBMAOANSD2L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009924-A1 Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives HUANG HSU-SHAN (TW) 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009924-A1 Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives NFE2L2, NR2F2, TFAM MAOB 1949/4885MAOA 1869/4885APP 2352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.